Literature DB >> 20130175

Gamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrin.

Guojun Zhao1, Zhenyi Liu, Ma Xenia G Ilagan, Raphael Kopan.   

Abstract

Gamma-secretase is a multiprotein, intramembrane-cleaving protease with a growing list of protein substrates, including the Notch receptors and the amyloid precursor protein. The four components of gamma-secretase complex--presenilin (PS), nicastrin (NCT), Pen2, and Aph1--are all thought to be essential for activity. The catalytic domain resides within PS proteins, NCT has been suggested to be critical for substrate recognition, and the contributions of Pen2 and Aph1 remain unclear. The role of NCT has been challenged recently by the observation that a critical residue (E332) in NCT, which had been thought to be essential for gamma-secretase activity, is instead involved in complex maturation. Here, we report that NCT is dispensable for gamma-secretase activity. NCT-independent gamma-secretase activity can be detected in two independent NCT-deficient mouse embryonic fibroblast lines and blocked by the gamma-secretase inhibitors N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester and L-685,458. This catalytic activity requires prior ectodomain shedding of the substrate and can cleave ligand-activated endogenous Notch receptors, indicating presence of this activity at the plasma membrane. Small interfering RNA knockdown experiments demonstrated that NCT-independent gamma-secretase activity requires the presence of PS1, Pen2, and Aph1a but can tolerate knockdown of PS2 or Aph1b. We conclude that a PS1/Pen2/Aph1a trimeric complex is an active enzyme, displaying biochemical properties similar to those of gamma-secretase and roughly 50% of its activity when normalized to PS1 N-terminal fragment levels. This PS1/Pen2/Aph1a complex, however, is highly unstable. Thus, NCT acts to stabilize gamma-secretase but is not required for substrate recognition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130175      PMCID: PMC2853942          DOI: 10.1523/JNEUROSCI.3826-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

1.  The initial substrate-binding site of gamma-secretase is located on presenilin near the active site.

Authors:  Anna Y Kornilova; Frédéric Bihel; Chittaranjan Das; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-18       Impact factor: 11.205

Review 2.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

3.  The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase.

Authors:  Aya Yamasaki; Stefan Eimer; Masayasu Okochi; Agata Smialowska; Christoph Kaether; Ralf Baumeister; Christian Haass; Harald Steiner
Journal:  J Neurosci       Date:  2006-04-05       Impact factor: 6.167

Review 4.  Nicastrin: gatekeeper of the gamma-secretase complex.

Authors:  Bart De Strooper
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

5.  Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components.

Authors:  Yun-wu Zhang; Wen-jie Luo; Hong Wang; Ping Lin; Kulandaivelu S Vetrivel; Fang Liao; Feng Li; Philip C Wong; Marilyn G Farquhar; Gopal Thinakaran; Huaxi Xu
Journal:  J Biol Chem       Date:  2005-02-11       Impact factor: 5.157

6.  Nicastrin functions as a gamma-secretase-substrate receptor.

Authors:  Sanjiv Shah; Sheu-Fen Lee; Katsuhiko Tabuchi; Yi-Heng Hao; Cong Yu; Quincey LaPlant; Haydn Ball; Charles E Dann; Thomas Südhof; Gang Yu
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

7.  Analysis of Notch function in presomitic mesoderm suggests a gamma-secretase-independent role for presenilins in somite differentiation.

Authors:  Stacey S Huppert; Ma Xenia G Ilagan; Bart De Strooper; Raphael Kopan
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

8.  Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo.

Authors:  Lutgarde Serneels; Tim Dejaegere; Katleen Craessaerts; Katrien Horré; Ellen Jorissen; Thomas Tousseyn; Sébastien Hébert; Marcel Coolen; Gerard Martens; An Zwijsen; Wim Annaert; Dieter Hartmann; Bart De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

9.  Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.

Authors:  A Herreman; D Hartmann; W Annaert; P Saftig; K Craessaerts; L Serneels; L Umans; V Schrijvers; F Checler; H Vanderstichele; V Baekelandt; R Dressel; P Cupers; D Huylebroeck; A Zwijsen; F Van Leuven; B De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

10.  Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein.

Authors:  Guojun Zhao; Guozhang Mao; Jianxin Tan; Yunzhou Dong; Mei-Zhen Cui; Seong-Hun Kim; Xuemin Xu
Journal:  J Biol Chem       Date:  2004-10-13       Impact factor: 5.157

View more
  42 in total

1.  Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates.

Authors:  Ping Gong; Kulandaivelu S Vetrivel; Phuong D Nguyen; Xavier Meckler; Haipeng Cheng; Maria Z Kounnas; Steven L Wagner; Angèle T Parent; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

Review 2.  Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

Authors:  Gael Barthet; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Prog Neurobiol       Date:  2012-05-20       Impact factor: 11.685

3.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

4.  Nicastrin functions to sterically hinder γ-secretase-substrate interactions driven by substrate transmembrane domain.

Authors:  David M Bolduc; Daniel R Montagna; Yongli Gu; Dennis J Selkoe; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

5.  Nicastrin is required for amyloid precursor protein (APP) but not Notch processing, while anterior pharynx-defective 1 is dispensable for processing of both APP and Notch.

Authors:  Chen Hu; Linlin Zeng; Ting Li; Michael A Meyer; Mei-Zhen Cui; Xuemin Xu
Journal:  J Neurochem       Date:  2016-01-17       Impact factor: 5.372

6.  Identification of a tetratricopeptide repeat-like domain in the nicastrin subunit of γ-secretase using synthetic antibodies.

Authors:  Xulun Zhang; Robert J Hoey; Guoqing Lin; Akiko Koide; Brenda Leung; Kwangwook Ahn; Georgia Dolios; Marcin Paduch; Takeshi Ikeuchi; Rong Wang; Yue-Ming Li; Shohei Koide; Sangram S Sisodia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

Review 7.  Targeting γ-secretase in breast cancer.

Authors:  Jianxun Han; Qiang Shen
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-06-21

8.  Functional and topological analysis of Pen-2, the fourth subunit of the gamma-secretase complex.

Authors:  Leen Bammens; Lucía Chávez-Gutiérrez; Alexandra Tolia; An Zwijsen; Bart De Strooper
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

9.  Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production.

Authors:  Yuan Tian; Christina J Crump; Yue-Ming Li
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

10.  Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin.

Authors:  I Hayashi; S Takatori; Y Urano; Y Miyake; J Takagi; M Sakata-Yanagimoto; H Iwanari; S Osawa; Y Morohashi; T Li; P C Wong; S Chiba; T Kodama; T Hamakubo; T Tomita; T Iwatsubo
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.